Deutsch English Français

Contact

EP0941089

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0941089

EP0941089 - USE OF ANTI-MICROTUBULE AGENTS FOR TREATING OR PREVENTING MULTIPLE SCLEROSIS [Right-click to bookmark this link]
Former [1999/37]	COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES
	[2000/23]
Status	No opposition filed within time limit Status updated on 22.03.2002 Database last updated on 02.09.2024
Most recent event Tooltip	26.09.2008	Change - representative	published on 29.10.2008 [2008/44]
Applicant(s)	For all designated states Angiotech Pharmaceuticals, Inc. 6660 N.W. Marine Drive Vancouver British Columbia V6T 1Z4 / CA
	[N/P]
Former [1999/37]	For all designated states Angiotech Pharmaceuticals, Inc. 6660 N.W. Marine Drive Vancouver, British Columbia V6T 1Z4 / CA
Inventor(s)	01 / HUNTER, William, L. 525 Penticton Street Vancouver, British Columbia V5K 3L7 / CA
	[1999/37]
Representative(s)	Gowshall, Jonathan Vallance, et al Forresters IP LLP Skygarden Erika-Mann-Strasse 11 80636 München / DE
	[N/P]
Former [2008/44]	Gowshall, Jonathan Vallance, et al Forrester & Boehmert Pettenkoferstrasse 20-22 80336 München / DE
Former [1999/37]	Gowshall, Jonathan Vallance, et al FORRESTER & BOEHMERT Franz-Joseph-Strasse 38 80801 München / DE
Application number, filing date	97945697.7	02.12.1997
	[1999/37]
	WO1997CA00910
Priority number, date	US19960032215P	02.12.1996 Original published format: US 32215 P
	US19970063087P	24.10.1997 Original published format: US 63087 P
	[1999/37]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO9824427
	Date:	11.06.1998
	Language:	EN
	[1998/23]
	Type:	A2 Application without search report
	No.:	EP0941089
	Date:	15.09.1999
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 11.06.1998 takes the place of the publication of the European patent application.
	[1999/37]
	Type:	B1 Patent specification
	No.:	EP0941089
	Date:	16.05.2001
	Language:	EN
	[2001/20]
Search report(s)	International search report - published on:	EP	01.10.1998
Classification	IPC:	A61K31/335, A61K31/22, A61K31/425, A61K31/36, A61K31/70, A61K33/08, A61K33/16	[1999/37]
	CPC:	B82Y5/00 (EP,US); A61K31/335 (EP,KR,US); A61K47/6957 (EP,US); A61K31/047 (EP,US); A61K31/08 (EP,US); A61K31/138 (EP,US); (+) A61K31/22 (EP,US); A61K31/223 (EP,US); A61K31/337 (EP,US); A61K31/352 (EP,US); A61K31/36 (EP,US); A61K31/366 (EP,US); A61K31/4015 (EP,US); A61K31/4025 (EP,US); A61K31/425 (EP,US); A61K31/426 (EP,US); A61K31/427 (EP,US); A61K31/437 (EP,US); A61K31/443 (EP,US); A61K31/4745 (EP,US); A61K31/475 (EP,US); A61K31/519 (EP,US); A61K31/70 (EP,US); A61K31/7064 (EP,US); A61K33/00 (EP,US); A61K33/06 (EP,US); A61K33/16 (EP,US); A61K47/10 (EP,US); A61K47/12 (EP,US); A61K47/14 (EP,US); A61K47/34 (EP,US); A61K47/6951 (EP,US); A61K49/0008 (EP,US); A61K9/0014 (EP,US); A61K9/0019 (EP,US); A61K9/0048 (EP,US); A61K9/06 (EP,US); A61K9/1075 (EP,US); A61K9/12 (EP,US); A61K9/1647 (EP,US); A61K9/5031 (EP,US); A61K9/5153 (EP,US); A61K9/7007 (EP,US); A61K9/7015 (EP,US); A61L31/10 (EP,US); A61L31/16 (EP,US); A61P1/00 (EP); A61P1/04 (EP); A61P11/00 (EP); A61P17/00 (EP); A61P17/06 (EP); A61P19/02 (EP); A61P25/00 (EP); A61P25/28 (EP); A61P29/00 (EP); A61P35/00 (EP); A61P37/00 (EP); A61P37/06 (EP); A61P41/00 (EP); A61P9/00 (EP); A61L2300/416 (EP,US); A61L2300/606 (EP,US) (-)
	C-Set:	A61K31/337, A61K2300/00 (EP,US)
Designated contracting states	AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1999/37]
Title	German:	VERWENDUNG VON ANTI-MIKROTUBULI MITTELN ZUR BEHANDLUNG UND PROPHYLAXE DER MULTIPLEN SCLEROSE	[2000/23]
	English:	USE OF ANTI-MICROTUBULE AGENTS FOR TREATING OR PREVENTING MULTIPLE SCLEROSIS	[2000/23]
	French:	UTILISATION DES AGENTS ANTI-MICROTUBULES POUR TRAITER OU PREVENIR LA SCLEROSE EN PLAQUES	[2000/23]
	Former [1999/37]	ZUSAMMENSETZUNGEN UND METHODE ZUR BEHANDLUNG UND PROPHYLAXE DER ENTZÜNDLICHEN ERKRANKUNGEN
	Former [1999/37]	COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES
	Former [1999/37]	COMPOSITIONS ET PROCEDES POUR TRAITER OU PREVENIR LES MALADIES INFLAMMATOIRES
Entry into regional phase	02.07.1999	National basic fee paid
	02.07.1999	Designation fee(s) paid
	02.07.1999	Examination fee paid
Examination procedure	23.06.1998	Request for preliminary examination filed International Preliminary Examining Authority: EP
	02.07.1999	Examination requested [1999/37]
	04.02.2000	Request for accelerated examination filed
	18.05.2000	Despatch of communication of intention to grant (Approval: Yes)
	18.05.2000	Decision about request for accelerated examination - accepted: Yes
	09.11.2000	Communication of intention to grant the patent
	19.02.2001	Fee for grant paid
	19.02.2001	Fee for publishing/printing paid
Divisional application(s)	EP00123534.0 / EP1092433
	EP00123537.3 / EP1090637
	EP00123557.1 / EP1070502
	EP05011601.1 / EP1582210
Opposition(s)	19.02.2002	No opposition filed within time limit [2002/19]
Fees paid	Renewal fee
	19.11.1999	Renewal fee patent year 03
	20.11.2000	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[Y]JPS6163613 ;
		[XY]EP0038567 (WELLCOME FOUND [GB]) [X] 7,8 * page 1, line 8 - page 2, line 14 * * claims 1-9 * [Y] 25-32;
		[X]EP0262681 (SCHERING CORP [US]) [X] 4-6 * page 2, line 15 - line 16 * * page 2, line 26 - line 28 * * claim 6 *;
		[XY]EP0288794 (MERRELL DOW PHARMA [US]) [X] 1 * page 1, line 14 - line 17 * * page 1, line 37 - line 39 * * page 7, line 4 - line 57 * * page 8, line 55 - page 9, line 1 * [Y] 25-32;
		[Y]WO9412158 (ALKERMES INC [US]) [Y] 25-31 * claims 1-6 *;
		[Y]WO9503795 (US GOV HEALTH & HUMAN SERV [US], et al) [Y] 10-15,25,27-30 * page 6, line 30 - page 7, line 2 * * page 9, line 26 - page 10, line 4 * * page 11, line 7 - line 15 * * examples 1,2 * * page 18, line 10 - line 24 * * page 20, line 4 - line 24 *;
		[Y]US5443458 (EURY ROBERT P [US]) [Y] 10-15,25,27-30 * column W *;
		[A]WO9535095 (YISSUM RES DEV CO [IL], et al) [A] 33* claims 1,6 *;
		[XY]EP0717041 (BRISTOL MYERS SQUIBB CO [US]) [X] 4 * column 6, line 51 - column 7, line 5 * [Y] 25-32;
		[X]US5565439 (PIAZZA GARY A [US], et al) [X] 4,6 * column 2, line 23 - line 39 *;
		[Y] - DATABASE WPI, 1, Derwent World Patents Index, vol. 86, no. 19, Database accession no. 86-123250, XP002062018 & JPS6163613 A 19860401 (MITSUI TOATSU CHEM. INC.) [Y] 25,26,29,32 * abstract *
		[Y] - YA MIN WANG ET AL., "Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, taxol", CHEM. PHARM. BULL., (1996), vol. 44, no. 10, pages 1935 - 1940, XP000633466 [Y] 25-30,32 * abstract *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p